Merck & Co Inc risk profile
35 Normal where most of the sector sits
Measured 21 October 2026 from MRK's filed statements. Recomputed nightly.
35 (Normal), driven by Concentration at 50, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 25 | Normal | Stable | One-year price volatility — 29.9% |
| Operating pressure | 31 | Normal | Worsening | Costs outgrowing revenue — -3.7 percentage points |
| Cash conversion | 31 | Normal | Worsening | Cash conversion — 0.90x |
| Leverage and coverage | 17 | Contained | Stable | Current ratio — 1.54x |
| Competitive position | 36 | Normal | Stable | Revenue-growth gap against peers — -20.3 percentage points |
| Concentration | 50 | Elevated | Stable | Geographic concentration — 3,732 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.